Skip to content

Type D personality and heart failure: burden of a life threatening cardiac condition in an aging population. A prospective follow-up study.

Type D personality and heart failure: burden of a life threatening cardiac condition in an aging population. A prospective follow-up study. - Type D personality and heart failure

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30293
Enrollment
400
Registered
2006-04-18
Start date
2006-04-24
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Universiteit van Tilburg
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients: Systolic heart failure; LVEF

Exclusion criteria

Exclusion criteria: Patients: Age >80 years; myocardial infarction during the month of inclusion; other life-threatening diseases; clinical signs of acute infection; co-morbid chronic inflammatory or auto-immune disease (e.g. Rheumatoid Arthritis); use of substantial anti-inflammatory medication (e.g. cortisol); evident cognitive impairments; chronic severe psychiatric condition (e.g. psychosis).;Partners: Evident cognitive impairments; chronic severe psychiatric condition (e.g. psychosis).

Design outcomes

Primary

MeasureTime frame
Personality (Type D and hostility) and mood are independent predictive variables. Mediating variables are immunoparameters and psychological variables (self-management and loneliness). Moderators are medical on the one hand (NYHA class, etiology), and psychological on the other hand (positive affectivity, sense of coherence and marital satisfaction). Primairy outcomes are defined as quality of life, health care utilization, and the combined endpoint of mortality and rehospitalizations.

Secondary

MeasureTime frame
The secundary endpoint is defined as cardiac mortality.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)